Entity Details

Primary name AFF2
Entity type gene
Source Source Link

Details

PrimaryID2334
RefseqGeneNG_016313
SymbolAFF2
NameAF4/FMR2 family member 2
ChromosomeX
LocationXq28
TaxID9606
Statuslive
SourceGenomegenomic
SourceOriginnatural
CreationDate1998-08-27
ModificationDate2021-06-11

Ontological Relatives

UniProt IDsAFF2_HUMAN

GO terms

Show/Hide Table
GOName
GO:0002151 G-quadruplex RNA binding
GO:0006397 mRNA processing
GO:0007420 brain development
GO:0007611 learning or memory
GO:0008380 RNA splicing
GO:0010468 regulation of gene expression
GO:0010629 negative regulation of gene expression
GO:0016607 nuclear speck
GO:0035063 nuclear speck organization
GO:0043484 regulation of RNA splicing

Diseases

Show/Hide Table
Disease IDSourceNameDescription
309548 OMIMMental retardation, X-linked, associated with fragile site FRAXE (MRFRAXE)A form of mild to moderate mental retardation associated with learning difficulties, communication deficits, attention problems, hyperactivity, and autistic behavior. It is associated with a fragile site on chromosome Xq28. Mental retardation is characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. The disease is caused by variants affecting the gene represented in this entry. It is caused either by silencing of the AFF2 gene as a consequence of a CCG expansion located upstream of this gene or by deletion within the gene. Loss of AFF2 expression is correlated with FRAXE CCG(N) expansion. Normal individuals have 6-35 copies of the repeat, whereas cytogenetically positive, developmentally delayed males have more than 200 copies and show methylation of the associated CPG island.

Interactions

6 interactions

InteractorPartnerSourcesPublicationsLink
AFF2CRKIntAct17474147 details
AFF2GRB2IntAct17474147 details
AFF2NCK1IntAct17474147 details
AFF2PLCG1IntAct17474147 details
AFF2AGR2BioGRID30575818 details
AFF2PHF1BioGRID29846670 details